CPF and ATS to Jointly Award $200,000 in research funding
TORONTO, May 21 /PRNewswire-USNewswire/ -- The Coalition for Pulmonary Fibrosis (CPF) and the American Thoracic Society (ATS), the world's leading professional organization for pulmonary, critical care and sleep physicians, today announced the expansion of their research partnership in pulmonary fibrosis. CPF and ATS are making available two new two-year, $100,000 awards for researchers in the United States pursuing new approaches to understand and treat pulmonary fibrosis.
"We'd like to express our gratitude to ATS for continuing a clinical partnership that is desperately needed in the research community to make new funds available to investigators dedicated to improving our understanding of IPF," said Marvin Schwarz, MD, James C. Campbell Professor of Pulmonary Medicine, Division of Pulmonary Sciences and Critical Care Medicine University of Colorado Denver and Chairman of the CPF Board of Directors.
ATS/CPF research awards are selected through a rigorous peer-review application process administered by ATS. Awards are selected from a series of applicants who submitted proposals in the areas of basic, clinical, genetic, and translational research that focus on identifying new approaches to understand or treating pulmonary fibrosis. The letter of intent deadline for the 2008 awards is 11:59 p.m. Eastern Time Wednesday, June 25, 2008 and the award recipients will be announced in December, 2008.
"We are proud to be able to match grants in this important area of research," said Thomas R. Martin, M.D., past president of ATS and Co-Chair of the ATS Research Program with Sharon Rounds. "The ATS continues its commitment to work with nationally recognized organizations like the CPF who are dedicated to advancing lung disease research."
The ATS/CPF Partnership Grant for Pulmonary Fibrosis was established in
2006. The first grant through this partnership was a $100,000, tw
|SOURCE Coalition for Pulmonary Fibrosis|
Copyright©2008 PR Newswire.
All rights reserved